Sorrento completes follow-on

On April 13, immunotherapy company Sorrento Therapeutics Inc. (NASDAQ:SRNE) raised $47.3 million through the sale of 23.6 million shares at $2 in a follow-on underwritten by Cantor Fitzgerald, FBR Ca...